Overview of Monocyte to Hdl Cholesterol Ratio (MHR) in Patients With Coronary Heart Disease (CHD)

Eki Frima Rizki, Elsi Indah Putri, James P Simanjuntak, Fardiah tilawati Sitanggang
{"title":"Overview of Monocyte to Hdl Cholesterol Ratio (MHR) in Patients With Coronary Heart Disease (CHD)","authors":"Eki Frima Rizki, Elsi Indah Putri, James P Simanjuntak, Fardiah tilawati Sitanggang","doi":"10.35910/icohpj.v2i0.716","DOIUrl":null,"url":null,"abstract":"Background: Coronary Heart Disease (CHD) is a disease caused by plaque that accumulates in the coronary arteries, causing narrowing or blockage of blood flow that supplies oxygen (O2) to the heart muscle. Monocytes accumulate in myocardial tissue experiencing hypoxia and play a role in the formation of atherosclerotic plaque. On the other hand, High-Density Lipoprotein (HDL) is known to reduce the accumulation of macrophages and prevent oxidized cholesterol from entering the artery walls. In the process of healing CHD, the number of monocytes decreases and HDL-cholesterol increases. This study aims to show the potential of the monocyte to HDL Cholesterol ratio as a marker for the prognosis of CHD patients. Method: This study used a case-control research design with a research sample of 50 CHD patients and 50 MCU patients at Bhayangkara Hospital, Jambi City. Result: From the results of the examination, the average monocyte cell count was 461.5 cells/μL, HDL-Cholesterol= 48.1 mg/dL and MHR value= 9.6. Meanwhile, in MCU patients, monocytes were 398 cells/μL, HDL-Cholesterol= 50.4 mg/dL and MHR value= 8.1. Conclusion: The MHR value of CHD patients was significantly higher than that of MCU patients. MHR appears to have good potential in the prognosis of CHD patients.","PeriodicalId":338971,"journal":{"name":"Proceeding International Conference Health Polytechnic of Jambi","volume":"48 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceeding International Conference Health Polytechnic of Jambi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35910/icohpj.v2i0.716","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Coronary Heart Disease (CHD) is a disease caused by plaque that accumulates in the coronary arteries, causing narrowing or blockage of blood flow that supplies oxygen (O2) to the heart muscle. Monocytes accumulate in myocardial tissue experiencing hypoxia and play a role in the formation of atherosclerotic plaque. On the other hand, High-Density Lipoprotein (HDL) is known to reduce the accumulation of macrophages and prevent oxidized cholesterol from entering the artery walls. In the process of healing CHD, the number of monocytes decreases and HDL-cholesterol increases. This study aims to show the potential of the monocyte to HDL Cholesterol ratio as a marker for the prognosis of CHD patients. Method: This study used a case-control research design with a research sample of 50 CHD patients and 50 MCU patients at Bhayangkara Hospital, Jambi City. Result: From the results of the examination, the average monocyte cell count was 461.5 cells/μL, HDL-Cholesterol= 48.1 mg/dL and MHR value= 9.6. Meanwhile, in MCU patients, monocytes were 398 cells/μL, HDL-Cholesterol= 50.4 mg/dL and MHR value= 8.1. Conclusion: The MHR value of CHD patients was significantly higher than that of MCU patients. MHR appears to have good potential in the prognosis of CHD patients.
冠心病 (CHD) 患者单核细胞与血清胆固醇比值 (MHR) 概览
背景:冠心病(CHD)是一种由冠状动脉中的斑块积聚引起的疾病,斑块积聚导致向心肌供应氧气(O2)的血流狭窄或阻塞。单核细胞积聚在缺氧的心肌组织中,在动脉粥样硬化斑块的形成过程中发挥作用。另一方面,高密度脂蛋白(HDL)可减少巨噬细胞的聚集,防止氧化胆固醇进入动脉壁。在治愈冠心病的过程中,单核细胞的数量会减少,而高密度脂蛋白胆固醇会增加。本研究旨在显示单核细胞与高密度脂蛋白胆固醇比值作为心脏病患者预后标志物的潜力。 研究方法本研究采用病例对照研究设计,研究样本为占碑市巴扬卡拉医院的 50 名心脏病患者和 50 名 MCU 患者。 结果检查结果显示,单核细胞平均为 461.5 个/μL,高密度脂蛋白胆固醇为 48.1 mg/dL,MHR 值为 9.6。而 MCU 患者的单核细胞为 398 个/μL,高密度脂蛋白胆固醇为 50.4 mg/dL,MHR 值为 8.1。 结论心脏病患者的 MHR 值明显高于 MCU 患者。MHR似乎在心脏病患者的预后方面具有良好的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信